OasisLMS

Topic: Education on vaccinations in patients with NMDs

Length: 30 minutes 

Learning Objectives:

• Assess infection risk in people with NMD
• Describe the effectiveness of vaccines in people with NMDs
• Identify risk mitigation strategies for specific infections associated with complement inhibitor therapies

Agenda / Content Focus:

• Brief overview of infections and NMDs- risk of infections in people with NMD, and NMD caused by specific infections
• Overview of data regarding the effectiveness of vaccines in the setting of immunosuppressive therapies
• Discussion of meningococcal infection risk and risk mitigation strategies in people receiving C5ITs

Webinar sponsored by Alexion.

Content from this presentation is not to be used without express written permission of the AANEM and the presenters involved in the presentation.